GNPX
Price
$0.52
Change
-$0.03 (-5.45%)
Updated
Jun 23, 04:04 PM (EDT)
Capitalization
6.04M
Intraday BUY SELL Signals
OTLK
Price
$1.71
Change
-$0.12 (-6.56%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
271.91M
Intraday BUY SELL Signals
Interact to see
Advertisement

GNPX vs OTLK

GNPX vs OTLK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GNPX vs. OTLK commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNPX is a Hold and OTLK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (GNPX: $0.55 vs. OTLK: $1.83)
Brand notoriety: GNPX and OTLK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNPX: 44% vs. OTLK: 73%
Market capitalization -- GNPX: $6.04M vs. OTLK: $271.91M
GNPX [@Biotechnology] is valued at $6.04M. OTLK’s [@Biotechnology] market capitalization is $271.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNPX’s FA Score shows that 1 FA rating(s) are green whileOTLK’s FA Score has 1 green FA rating(s).

  • GNPX’s FA Score: 1 green, 4 red.
  • OTLK’s FA Score: 1 green, 4 red.
According to our system of comparison, OTLK is a better buy in the long-term than GNPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNPX’s TA Score shows that 5 TA indicator(s) are bullish while OTLK’s TA Score has 6 bullish TA indicator(s).

  • GNPX’s TA Score: 5 bullish, 2 bearish.
  • OTLK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, GNPX is a better buy in the short-term than OTLK.

Price Growth

GNPX (@Biotechnology) experienced а +13.52% price change this week, while OTLK (@Biotechnology) price change was +57.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was +3.26%, and the average quarterly price growth was +1969.89%.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OTLK($272M) has a higher market cap than GNPX($6.04M). OTLK has higher P/E ratio than GNPX: OTLK (0.59) vs GNPX (0.08). OTLK YTD gains are higher at: 15.823 vs. GNPX (-68.434). GNPX has higher annual earnings (EBITDA): -16.01M vs. OTLK (-57.09M). GNPX has more cash in the bank: 18M vs. OTLK (7.75M). GNPX has less debt than OTLK: GNPX (279K) vs OTLK (27.2M). OTLK has higher revenues than GNPX: OTLK (333K) vs GNPX (0).
GNPXOTLKGNPX / OTLK
Capitalization6.04M272M2%
EBITDA-16.01M-57.09M28%
Gain YTD-68.43415.823-433%
P/E Ratio0.080.5913%
Revenue0333K-
Total Cash18M7.75M232%
Total Debt279K27.2M1%
FUNDAMENTALS RATINGS
GNPX vs OTLK: Fundamental Ratings
GNPX
OTLK
OUTLOOK RATING
1..100
6045
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9534
P/E GROWTH RATING
1..100
9725
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GNPX's Valuation (6) in the Pharmaceuticals Major industry is significantly better than the same rating for OTLK (79) in the Biotechnology industry. This means that GNPX’s stock grew significantly faster than OTLK’s over the last 12 months.

GNPX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as OTLK (100) in the Biotechnology industry. This means that GNPX’s stock grew similarly to OTLK’s over the last 12 months.

GNPX's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as OTLK (100) in the Biotechnology industry. This means that GNPX’s stock grew similarly to OTLK’s over the last 12 months.

OTLK's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for GNPX (95) in the Pharmaceuticals Major industry. This means that OTLK’s stock grew somewhat faster than GNPX’s over the last 12 months.

OTLK's P/E Growth Rating (25) in the Biotechnology industry is significantly better than the same rating for GNPX (97) in the Pharmaceuticals Major industry. This means that OTLK’s stock grew significantly faster than GNPX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNPXOTLK
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 16 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GNPX
Daily Signal:
Gain/Loss:
OTLK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBRRX29.590.07
+0.24%
Neuberger M/C Intrinsic Val R3
OSGIX40.55N/A
N/A
JPMorgan Mid Cap Growth A
TWQAX18.67N/A
N/A
Transamerica Large Cap Value A
NSCFX62.14N/A
N/A
Nuveen Small-Cap Value Opps R6
PMIVX11.72N/A
N/A
Putnam Multi-Asset Income R6

GNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been closely correlated with CANF. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if GNPX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
-6.69%
CANF - GNPX
93%
Closely correlated
+2.68%
APVO - GNPX
91%
Closely correlated
+2.57%
ICU - GNPX
87%
Closely correlated
+3.69%
MLEC - GNPX
86%
Closely correlated
-2.32%
LNAI - GNPX
84%
Closely correlated
+10.58%
More